VBI Vaccines
VBIV
#10708
Rank
NZ$3.13 M
Marketcap
NZ$0.11
Share price
0.00%
Change (1 day)
-89.30%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): NZ-$16.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is NZ-$16.97. In 2022 the company made an earnings per share (EPS) of NZ-$22.08 a decrease over its 2021 EPS that were of NZ-$13.55.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$16.49
2022NZ-$22.0862.96%
2021NZ-$13.5528.57%
2020NZ-$10.54-54.35%
2019NZ-$23.09-52.58%
2018NZ-$48.6910.23%
2017NZ-$44.1714.29%
2016NZ-$38.65-62.8%
2015NZ-$103.9090.68%
2014NZ-$54.49-7.95%
2013NZ-$59.20-57.97%
2012NZ-$140.86-78%
2011NZ-$640.383151.47%
2010NZ-$19.7023.87%
2009NZ-$15.90-18.48%
2008NZ-$19.5112.08%
2007NZ-$17.40-49.47%
2006NZ-$34.44
2005N/A-100%
2004NZ-$15.3111.94%
2003NZ-$13.68-81.89%
2002NZ-$75.53196.44%
2001NZ-$25.4884.33%
2000NZ-$13.82-65.37%
1999NZ-$39.92-29.45%
1998NZ-$56.5829.61%
1997NZ-$43.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
NZ-$1.59-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
NZ-$6.14-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$7.24-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA